Ifosfamide

Penile Cancer

Fudan UniversityPhase 2Active

CCC

53/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 38/ 100
Competitive Position: 89/ 100

Competitive context

15 Active assets in the Penile Cancer cohort.

Asset / Sponsor	Phase	Rating
Cyclophosphamide Christian Hinrichs	Phase 2	BB
Fludarabine Christian Hinrichs	Phase 2	BB
CIS-DIAMMINEDICHLOROPLATINUM II Fudan University	Phase 2	B
e7 tcr-t cells Christian Hinrichs	Phase 2	B
9-valent human papillomavirus recombinant vaccine Shanghai Bovax Biotechnology Co., Ltd.	Phase 3	B

View all 23 →

Same molecule, other indications

Ifosfamide is also rated in:

angioimmunoblastic T-cell lymphomaDormant

BBB

Indicative ·

76 / 100

primary mediastinal large B-cell lymphomaDormant

BBB

Indicative ·

76 / 100

Hodgkins lymphomaDormant

BBB

Indicative ·

73 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.